Methotrexat

Methotrexate, the active ingredient in Methotrexat, is an antimetabolite (folate antagonist) presented as a sterile injectable solution for intramuscular, intrathecal, and intravenous use. It is employed to treat autoimmune disorders and certain malignancies in adult and pediatric patients. GNH USA supplies Methotrexat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide.

Methotrexat is an antimetabolite that interferes with rapidly dividing cells and modulates immune activity, making it useful across several disease families. - Rheumatoid arthritis: reduces disease activity and joint inflammation. - Psoriasis: decreases skin plaque formation and severity. - Acute lymphoblastic leukemia: induces remission by halting leukemic cell proliferation. - Non‑Hodgkin lymphoma: contributes to tumor control as part of combination chemotherapy. - Osteosarcoma: used in high‑dose regimens to target bone tumor cells. - Gestational trophoblastic disease: promotes resolution of abnormal trophoblastic tissue.

Methotrexat may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects: - Nausea or vomiting - Fatigue or malaise - Oral mucosal ulceration - Transient elevation of liver enzymes

Serious or Rare Side Effects: - Severe hepatotoxicity or fibrosis - Pulmonary fibrosis or interstitial pneumonitis - Bone marrow failure with pancytopenia - Acute renal insufficiency or failure

Methotrexat requires careful monitoring and specific safety measures before and during therapy. - Pregnancy: contraindicated (Category X); avoid use in pregnant or planning patients. - Renal function: assess baseline creatinine and adjust dose if impaired. - Hepatic function: monitor liver enzymes regularly; avoid in severe liver disease. - Hematologic status: perform complete blood counts before each dose to detect myelosuppression. - Drug interactions: avoid concurrent high‑dose NSAIDs and live vaccines. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Methotrexat can interact with several medicines, altering its safety profile or efficacy.

Major Interactions (Avoid): - Live vaccines: increased risk of severe infection. - High‑dose NSAIDs: heightened methotrexate toxicity. - Penicillamine: synergistic myelosuppression.

Moderate Interactions (Monitor Closely): - Sulfonamides: additive bone‑marrow suppression. - Proton‑pump inhibitors: may affect renal clearance. - Azathioprine or other immunosuppressants: enhanced immunosuppression.